Funding providers

DigestScience is supported by major health care and research players in France.

Ferring Pharmaceuticals

Ferring Pharmaceuticals is a research-driven biopharmaceutical company devoted to identifying, developing and marketing innovative products in the fields of reproductive health, urology, gastroenterology, endocrinology and osteoarthritis. The company's research activities and products are connected by a common thread focused on the provision of tailored treatments that work on the body's own terms to enable doctors to combat numerous diseases and medical conditions.

The company has gained international recognition over the last 20 years for the creation of inventive medications that improve the quality of life of children and adults all around the world.

http://www.ferring.com

 

Giuliani

Founded in 1889, over the years Giuliani has successfully developed high-quality products and has contributed to promoting pharmaceutical awareness among the public, becoming one of Italy's time-honored, well known and highly esteemed pharmaceutical manufacturers.
The company aims to consolidate its leadership by continually launching innovative products and entering emerging markets consistently with its know how.

The company continues to focus on the gastrointestinal, nutraceutical and Dermatological areas.

http://www.giulianipharma.com/eng/index.htm

 

Schering Plough

With over 55,000 employees globally, Schering-Plough is one of the world's largest pharmaceutical companies.

It has developed several innovative treatments for inflammatory bowel diseases.

http://www.sch-plough.com

 

The François Aupetit Association (AFA)

The François Aupetit Association is a registered charity for French IBD patients.

The AFA funds many research programmes in this field and thus very naturally linked up with the DigestScience foundation in order to help fund research on these very widespread digestive tract diseases.

http://www.afa.asso.fr

 

Abbott

 Abbott is an international human health group, committed to researching, developing, manufacturing and marketing pharmaceuticals, including nutritional products and surgical and diagnostic devices. The group employs 68,000 people and markets its products in over 130 countries worldwide.

In recent years, Abbott has become increasingly involved in diagnostic and therapeutic research on autoimmune diseases, particularly in the fields of rheumatology, gastroenterology and dermatology.

In gastroenterology, Abbott focuses research and development on inflammatory diseases of the digestive tract and, in particular, on the use and efficacy of adalimumab in Crohn's disease.

 

The French Gluten Intolerance Association (AFDIAG)

The AFDIAG was founded by patients suffering from coeliac disease.

In addition to its goal of informing, helping and defending patients, the AFDIAG is very involved in research - notably through its membership of the GERMC (the Coeliac Disease Research and Study Group). www.afdiag.org

http://www.afdiag.org

 

MICI-VIDI-VICI

MICI -VIDI-VICI is a recently-formed IBD patient association which has followed on from the success of the lacrohnique.com web site.

http://www.lacrohnique.com/smartsection.item.60/association-mici-vidi-vici-et-le-site-la-crohnique.html

 

 

Lille University Medical Centre

Lille University Medical Centre comprises 11 hospitals and is the largest university hospital complex in northern Europe.

Lille University Medical Centre has unique expertise in digestive tract disease and is particularly committed to research and clinical trials in a region that is highly affected by Crohn's disease. Its involvement demonstrates the intention of seeing DigestScience-funded research rapidly translated into actual patient care.

http://www.chru-lille.fr

 

Inserm

The INSERM includes France's best medical research groups and is the only national research institute entirely dedicated to human health.

Its participation in DigestScience testifies to the foundation's intention to federate research promoters around the issue of digestive tract diseases.

http://www.inserm.fr

 

University of Lille 2

With almost 30,000 students, the University of Lille 2 is one of Europe's major higher education institutions, notably in the field of healthcare.

Medical research is very important at the University of Lille 2 and the latter's participation in DigestScience's activities underlines its commitment to projects which advance scientific and medical research, healthcare, teaching and training.

http://www.univ-lille2.fr

 
Subscribe to our newsletter!
Newsletter en français
Newsletter in english

Un sponsor XXL pour le Team DigestScience

Les Chalets Grosset Janin, profondément attachés aux valeurs véhiculées par la Fondation, soutiennent la recherche sur les maladies digestives en devenant partenaire privilégié de son Team sportif.

Read more…


Le Team DigestScience reprend la route

1ere sortie de l'année 2012 pour notre team sportif  avec Cédric Vasseur à sa tête !

Read more…


1,300 Participants and 10,500 euros for research

A resounding success for the 6th Testathlon !

Read more…